A study on the correlation between the prognosis and the perioperative level of serum ulinastatin

A controlled study on the correlation between the prognosis and the perioperative level of serum uli

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCC-14004867

Enrollment

Unknown

Registered

2014-06-28

Start date

2014-08-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative inflammatory reaction

Interventions

Hysteroscope group:No intervention measure

Bone tumor group:No intervention measure

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Bone tumor group: 30 patients: 18-65 years old, selective operation for bone tumor, expected length of surgery more than 3 hours;Hysteroscope group: 30 patients: 18-65 years old, selective operation for hysteroscope surgeries, expected length of surgery less than 30 minutes.

Exclusion criteria

Exclusion criteria: History of autoimmune disease, severe inflammatory response or stressed (infection, sepsis, trauma) before operation, hyperresponsiveness(asthma), liver damage(ALT, AST 1.5 times higher than normal), kidney damage(creatinine higher than normal), length of surgery less than 3 hours for bone tumor surgeries or length of surgery less than 30 minutes for hysteroscope surgeries, hormone used during the surgery.

Design outcomes

Primary

Measure	Time frame
CRP;IL6;IL10;	—

Contacts

Public ContactFeng Yi

Peking University People's Hospital

fengyi@pkuph.edu.cn+86 10 88325590

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026